BioCentury
ARTICLE | Clinical News

sNN0029 regulatory update

November 16, 2009 8:00 AM UTC

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for NeuroNova's sNN0029 to treat amyotrophic lateral sclerosis (ALS). The vascular end...